Cellectar Receives USPTO Notice of Allowance for Patent Covering Use of CLR 131 in Multiple Myeloma
Feb 07, 2018 13:15 pm UTC| Business
MADISON, Wis., Feb. 07, 2018 -- Cellectar Biosciences (Nasdaq:CLRB), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, announces...
Feb 07, 2018 13:15 pm UTC| Business
NEW YORK, Feb. 07, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Graphic Packaging...
Feb 07, 2018 13:10 pm UTC| Business
NEW YORK, Feb. 07, 2018 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Dow Chemical...
Catalyst Pharmaceuticals to Present at Two Upcoming Investor Conferences
Feb 07, 2018 13:03 pm UTC| Business
CORAL GABLES, Fla., Feb. 07, 2018 -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating,...
Feb 07, 2018 13:02 pm UTC| Business
ALBANY, New York, Feb. 07, 2018 -- Workers and employees in almost every industry are subjected to hazards which can permanently or temporarily injure them. Employers are compelled to provide proper protection equipment...
Feb 07, 2018 13:02 pm UTC| Business
VALLEY COTTAGE, NY, Feb. 07, 2018 -- According to a recent research analysis compiled by Future Market Insights (FMI), a CAGR of over 20% has been projected for the global market for medication management system during...
Columbus Obtains New Trading Symbol on OTCQX
Feb 07, 2018 13:02 pm UTC| Business
VANCOUVER, British Columbia, Feb. 07, 2018 -- Columbus Gold Corp. (TSX:CGT) (OTCQX:CGTFF) is pleased to announce that it has obtained a new trading symbol on the OTCQX Best Market. Effective today, Columbus’ trading...